Barclays Reiterates an 'Equalweight' on DPL (DPL); Repurchase Plan Suspended: Revising our Estimates
Get Alerts DPL Hot Sheet
Price: $30.19 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Barclays reiterates an 'Equalweight' on DPL (NYSE: DPL), PT $30.
Barclays analyst says, "DPL reported Q1 operating EPS of $0.56 v. our $0.65E and compared to $0.61 in Q1 '09: This result excludes a $0.09 charge associated with DPL's debt purchase premium and write-off, $0.05 in tax adjustments and $0.04 in storm costs. DPL announced a suspension of its share repurchase program as a result of the merger agreement announced with AES on April 20, 2011. 2 million shares were repurchased in Q4 '10 at an average price of $25.75; no shares were repurchased in Q1 '11. We are lowering our '11/'12E from $2.50/$2.56 to $2.43/$2.45 to reflect a forecasted higher share count."
For more ratings news on DPL click here and for the rating history of DPL click here.
Shares of DPL closed at $30.29 yesterday.
Barclays analyst says, "DPL reported Q1 operating EPS of $0.56 v. our $0.65E and compared to $0.61 in Q1 '09: This result excludes a $0.09 charge associated with DPL's debt purchase premium and write-off, $0.05 in tax adjustments and $0.04 in storm costs. DPL announced a suspension of its share repurchase program as a result of the merger agreement announced with AES on April 20, 2011. 2 million shares were repurchased in Q4 '10 at an average price of $25.75; no shares were repurchased in Q1 '11. We are lowering our '11/'12E from $2.50/$2.56 to $2.43/$2.45 to reflect a forecasted higher share count."
For more ratings news on DPL click here and for the rating history of DPL click here.
Shares of DPL closed at $30.29 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- AMD (AMD) to offer senior notes in four parts
- Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Barclays, Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share